Fig. 3

Seventy-two-year old man with high grade muscle-invasive urothelial bladder cancer on transurethral resection. MRI performed after 3 cycles of neoadjuvant gemcitabine + cisplatin, showed residual focal wall thickening (arrow) in the anterior bladder wall on axial T2-weighted imaging (A). There was no abnormal high signal on axial diffusion-weighed imaging (B) but mild ill-defined enhancement was noted on sagittal post-contrast MRI (C). At radical cystectomy, there was a 0.5-cm focus of residual tumor in situ (ypTis). Patient was alive without recurrence at 792 days after surgery